Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vistin Pharma ASA ( (DE:VP4) ) has provided an update.
Vistin Pharma ASA’s Chair of the Board, Øyvin Brøymer, has received open proxies to represent 11.63% of the company’s shares at the Annual General Meeting, bringing his total representation to 44.35% of the shares. This significant shareholding could influence the decisions made at the AGM, impacting the company’s strategic direction and stakeholder interests.
More about Vistin Pharma ASA
Average Trading Volume: 54,995
Current Market Cap: NOK1.11B
See more insights into VP4 stock on TipRanks’ Stock Analysis page.